Extended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time
- PMID: 24833818
- PMCID: PMC4021646
- DOI: 10.4103/0974-7796.130536
Extended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time
Abstract
Objective: Recently, many articles reported increased incidence of urinary tract infection (UTI) due to Extended-Spectrum Beta-Lactamase (ESBL)-producing E. coli. No data are available to date regarding patients presenting with complicated upper ESBL-positive E. coli UTI and sepsis. We report the clinical presentation, management, and outcomes in seven cases.
Materials and methods: This prospective study was carried out between January 2008 and September 2011. Follow-ups varied in patients according to their disease presentation and clinical outcomes. All strains were cultured and identified by the Clinical Microbiology Laboratory and were recovered from blood and urine cultures. In-vitro presence of ESBL was confirmed with Clinical and Laboratory Standard Institute double disc method.
Results: In the study period, 49 patients needed hospitalization for upper UTI. Overall, in 25 patients (51%), cultures were negative. In the remaining, seven patients (14.3%) presented positive blood and urine-culture for ESBL + E. coli. Of these, four were female and three were male. Their median age was 73 years (range 66-84). The median hospital stay of these patients was 23 days (range 13 to 45 days).
Conclusions: The current situation of multiple bacterial antibiotic resistance has become a worrisome issue in UTI. Multi-drug-resistant E. coli can be readily encountered in hospital settings during daily clinical practice, and urologist should act timely. The management of such infections is extremely important for the future, with particular reference to prevention of new antibiotic resistance patterns.
Keywords: Escherichia coli; Extended-spectrum beta-lactamase positive; hydronephrosis; infection; pyonephrosis; sepsis.
Conflict of interest statement
Similar articles
-
Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.BMC Infect Dis. 2017 Feb 10;17(1):138. doi: 10.1186/s12879-017-2250-y. BMC Infect Dis. 2017. PMID: 28187754 Free PMC article.
-
Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.J Microbiol Immunol Infect. 2014 Oct;47(5):399-405. doi: 10.1016/j.jmii.2013.05.006. Epub 2013 Jul 6. J Microbiol Immunol Infect. 2014. PMID: 23834784
-
Risk factors for community acquired pediatric urinary tract infection with extended-spectrum-β-lactamase Escherichia coli - A case-control study.J Pediatr Urol. 2023 Feb;19(1):129.e1-129.e7. doi: 10.1016/j.jpurol.2022.10.020. Epub 2022 Oct 18. J Pediatr Urol. 2023. PMID: 36344365
-
Increasing Prevalence of Pediatric Community-acquired UTI by Extended Spectrum β-Lactamase-producing E. coli: Cause for Concern.Pediatr Infect Dis J. 2023 Feb 1;42(2):106-109. doi: 10.1097/INF.0000000000003777. Epub 2022 Nov 15. Pediatr Infect Dis J. 2023. PMID: 36638394 Review.
-
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.Drugs. 2022 Apr;82(5):533-557. doi: 10.1007/s40265-022-01688-1. Epub 2022 Mar 16. Drugs. 2022. PMID: 35294769 Review.
Cited by
-
The Frequency of Antibiotic Resistance and ESBLs Among Clinically Acinetobacter baumannii Strains Isolated from Patients in a Major Hospital in Tehran, Iran.Open Microbiol J. 2018 Jul 31;12:254-260. doi: 10.2174/1874285801812010254. eCollection 2018. Open Microbiol J. 2018. PMID: 30197699 Free PMC article.
-
Antibiotic prescribing for acute uncomplicated cystitis in Lebanese community pharmacies using a simulated patient.Pharm Pract (Granada). 2019 Oct-Dec;17(4):1604. doi: 10.18549/PharmPract.2019.4.1604. Epub 2019 Dec 12. Pharm Pract (Granada). 2019. PMID: 31897255 Free PMC article.
-
The Antibacterial Activity of Human Amniotic Membrane against Multidrug-Resistant Bacteria Associated with Urinary Tract Infections: New Insights from Normal and Cancerous Urothelial Models.Biomedicines. 2021 Feb 20;9(2):218. doi: 10.3390/biomedicines9020218. Biomedicines. 2021. PMID: 33672670 Free PMC article.
-
Antibiotic-resistant Enterobacteriaceae in healthy gut flora: A report from north Indian semiurban community.Indian J Med Res. 2019 Feb;149(2):276-280. doi: 10.4103/ijmr.IJMR_207_18. Indian J Med Res. 2019. PMID: 31219094 Free PMC article.
-
Rapid in vitro detection of CTX-M groups 1, 2, 8, 9 resistance genes by LAMP assays.PLoS One. 2018 Jul 18;13(7):e0200421. doi: 10.1371/journal.pone.0200421. eCollection 2018. PLoS One. 2018. PMID: 30021007 Free PMC article.
References
-
- Stamm WE. The epidemiology of urinary tract infections: Risk factors reconsidered. Inter Sci Conf Antimicrob Agents Chemother. 1999;39:769.
-
- World Health Organization. Report on infectious diseases 2000: overcoming antimicrobial resistance. [Last accessed on 2000 Sep 23]. Available from: http://www.who.int/infectious.disease.report/index.html .
-
- Centers for Disease Control and Prevention. Preventing emerging infectious diseases. [Last accessed on 2000 Sep 20]. Available from: http://www.cdc.gov/ncidod/emergplan/plan98.pdf .
-
- European Community. A strategy against the microbial threat. Official Journal of the European Community. Council Resolution of 8 June 1999 on antibiotic resistance. Official Journal C 195, 13/07/1999. [Last accessed on 2000 Sep 29]. pp. 1–3. Available from: http://europa.eu.int/eurex/en/lif/dat/1999/en_399Y0713_01.html .
LinkOut - more resources
Full Text Sources
Other Literature Sources